NovoCure (NVCR) Change in Receivables (2017 - 2023)
NovoCure (NVCR) posted Change in Receivables of -$2.6 million for Q3 2023, up 61.94% sequentially from -$6.9 million in Q2 2023, and up 77.07% YoY from -$1.5 million in Q3 2022.
NovoCure (NVCR) Change in Receivables (2017 - 2023) Analysis & Trends
NovoCure has reported Change in Receivables for 7 years, with the latest figure at -$2.6 million in Q3 2023.
- Quarterly Change in Receivables rose 77.07% year-over-year to -$2.6 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$20.3 million (down 165.14% YoY) and the FY2022 annual result came in at -$2.5 million, up 51.67% from the prior year.
- Change in Receivables climbed to -$2.6 million in Q3 2023 per NVCR's latest filing, from -$6.9 million in the prior quarter.
- Over five years, Change in Receivables peaked at $19.7 million in Q1 2020 and troughed at -$14.5 million in Q1 2023.
- A 5-year average of $1.8 million and a median of $2.0 million in 2019 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2020 and 2022: Change in Receivables surged 868.47% in 2020, then plunged 409.23% in 2022.
- Over 5 years, Change in Receivables stood at $19.5 million in 2019, then slumped by 116.44% to -$3.2 million in 2020, then soared by 57.93% to -$1.3 million in 2021, then surged by 379.96% to $3.8 million in 2022, then sank by 170.06% to -$2.6 million in 2023.
- According to Business Quant data, Change in Receivables over the past three periods registered -$2.6 million, -$6.9 million, and -$14.5 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -2.64 Mn |
| Sep 30, 2023 | -2.64 Mn |
| Jun 30, 2023 | -6.94 Mn |
| Jun 30, 2023 | -6.94 Mn |
| Mar 31, 2023 | -14.51 Mn |
| Mar 31, 2023 | -14.51 Mn |
| Dec 31, 2022 | 3.77 Mn |
| Dec 31, 2022 | 3.77 Mn |
| Sep 30, 2022 | -11.52 Mn |
| Sep 30, 2022 | -11.52 Mn |
| Jun 30, 2022 | -2.26 Mn |
| Jun 30, 2022 | -2.26 Mn |
| Mar 31, 2022 | 7.46 Mn |
| Mar 31, 2022 | 7.46 Mn |
| Dec 31, 2021 | -1.35 Mn |
| Dec 31, 2021 | -1.35 Mn |
| Sep 30, 2021 | 3.73 Mn |
| Sep 30, 2021 | 3.73 Mn |
| Jun 30, 2021 | -3.03 Mn |
| Jun 30, 2021 | -3.03 Mn |